TIGIT / VSTM3 / VSIG9 (Immune Checkpoint for Cancer)(TIGIT/3106), CF640R conjugate, 0.1mg/mL

Produktübersicht

• Artikelname: TIGIT / VSTM3 / VSIG9 (Immune Checkpoint for Cancer)(TIGIT/3106), CF640R conjugate, 0.1mg/mL
• Artikelnummer: BOT-BNC403106-500
• Hersteller Artikelnummer: BNC403106-500
• Alternativnummer: BOT-BNC403106-500-500UL
• Hersteller: Biotium
• Kategorie: Antikörper
• Applikation: IHC-P
• Konjugation: CF640R

Produktbeschreibung

TIGIT is a checkpoint inhibitor which binds with high affinity to the poliovirus receptor (PVR), causing increased IL10 secretion, decreased IL12B secretion. TIGIT binding to PVR also causes the suppression of T cell activation by promoting the generatio

Produkteigenschaften

• Konzentration: 0.1 mg/mL
• Puffer: PBS, 0.1% BSA, 0.05% azide
• Quelle: Animal